Industry News
Leap in survival rates for childhood leukaemia patients with rare genetic abnormality
Aug 15, 2013
A pioneering genetic study means that children with a rare subtype of leukaemia have 75% less chance of their leukaemia recurring... Read More
Employers can play a role in cancer prevention and treatment
Aug 15, 2013
Employers can have a significant role in improving efforts to prevent and treat diseases such as cancer by introducing and supporting health promotion programs in the workplace. Together, companies can influence health care policies and reimbursement and industry practices to support the fight against cancer... Read More
Children with high-risk neuroblastoma benefit from new, precise proton therapy cancer treatment
Aug 15, 2013
Proton therapy, using high-energy subatomic particles, may offer a precise, organ-sparing treatment option for children with high-risk forms of neuroblastoma. For patients in a new study of advanced radiation treatment, proton therapy spared the liver and kidneys from unwanted radiation, while zeroing in on its target... Read More
HPV-related tonsillar cancer on the rise in Canada
Aug 15, 2013
American and European research shows an alarming increase in the rate of tonsillar cancer related to the human papilloma virus (HPV), a sexually transmitted virus. Experts suggest a similar trend has emerged in Canada, but it had yet to be confirmed through scientific analysis... Read More
Breastfeeding reduces threat of breast cancer
Aug 15, 2013
Women who breastfeed for over 6 months are less likely to develop early breast cancer than women who do not breastfeed - as long as they do not smoke - a nurse-led study suggests... Read More
Low-grade prostate cancers may not become aggressive with time - adds support for "watch and wait" approach
Aug 15, 2013
Prostate cancer aggressiveness may be established when the tumor is formed and not alter with time, according to a study published in Cancer Research, a journal of the American Association for Cancer Research... Read More
Researchers have developed an experimental therapy that can kill human blood cancer cells in the laboratory and eradicate the disease in mice
Aug 15, 2013
Ottawa researchers have developed unique virus-derived particles that can kill human blood cancer cells in the laboratory and eradicate the disease in mice with few side effects. The study is published in Blood Cancer Journal by co-senior authors Drs. David Conrad and John Bell of the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa (uOttawa). While Dr... Read More
CDK6 represents a promising target for anti-cancer therapy
Aug 15, 2013
Cell division is tightly controlled by a number of genes and because of the importance of ensuring that the process stays in check - mistakes frequently lead to cancer - mammalian cells often have several inbuilt layers of security... Read More
Mice experience therapeutic changes in glioma after transplantation of neural stem cells
Aug 15, 2013
Neural stem cells transplanted into tumor-bearing rats can hinder tumor cell growth and proliferation; however, the mechanism remains unclear. Abnormal activation of the Ras/Raf/Mek/Erk signaling cascade plays an important role in glioma. Inhibition of this aberrant activity could effectively hinder glioma cell proliferation and promote cell apoptosis... Read More
Breastfeeding cuts breast cancer risks for moms
Aug 15, 2013
Women who breastfeed for over 6 months are less likely to develop early breast cancer than women who do not breastfeed - as long as they do not smoke - a nurse-led study suggests... Read More
Previous Page Next Page